United States · 
What does Biomatics Capital invest in?
Biomatics Capital invests most often at Series A and Series B (91% of the rounds on record), in sectors such as Diagnostics, Ivd and Bioimaging.
Biomatics Capital highlights
- 01
12 rounds on record
- 02
Mostly Series A and Series B: 91% of its rounds
- 03
Sole investor in 1 rounds, median $20M
What they do
Biomatics Capital is a for-profit venture firm investing in transformational data enabled innovation at the intersection of health care and technology.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $5.0M – $20M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- DiagnosticsIvdBioimaging
- Based in
- Seattle, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first12 appearances
- 2019
5 rounds
- Nov
- Nov
- Jun
- May
- May
- 2018
4 rounds
- Oct
- Jul
- Jul
- Jun
- 2017
3 rounds
- Mar
- Jan
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
BNBoris NikolicManaging Member of the General PartneriFiling they signed
JEJulie Estelle SunderlandManaging Member of the General PartneriFiling they signed
We also hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$141Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Biomatics Management Company, LLC
- SEC number
- CRD 284637